Kenji Iwaya is a department manager at Hanshin Holdings, leading their NexCulture project. He spearheads the companys venture into regenerative medicine, focusing on developing a DX platform that utilizes AI to innovate and streamline cell culture research and development for the biotech industry.
He is pioneering the digitalization of cell culture within a traditional conglomerate, bridging the gap between established industry and cutting-edge biotech innovation.
KENJI IWAYA
経営企画室 部長 at 阪神ホールディングス株式会社
Chiba, Japan
Overview
Topics They Care About
Regenerative Medicine
As the General Manager of the Regenerative Medicine Department, he leads Hanshin Holdings' strategic projects in the life sciences and biotech fields.
Biotech Digitalization
He is the driving force behind the "NexCulture" platform, which aims to digitalize cell culture processes to enhance research efficiency and reproducibility.
AI in Research
His project leverages AI for the automatic analysis of cell culture data, aiming to improve accuracy and reduce manual labor for researchers.
Media Appearances
KENJI has no verified media appearances
Work History
1-2018
経営企画室 部長 at 阪神ホールディングス株式会社
Education
KENJI has no verified education history
More Information
Social Presence :
Prographics :
Exp : 7
Location : Chiba, Japan
Job Level : N/A
Designation : 経営企画室 部長 at 阪神ホールディングス株式会社
